Change - Announcement of Cessation::Resignation of Non-Executive and Independent Director

Issuer & Securities

Issuer/ Manager
V2Y CORPORATION LTD.
Securities
V2Y CORPORATION LTD. - SGXE31442804 - V2Y
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
13-Sep-2024 18:38:26
Status
New
Announcement Sub Title
Resignation of Non-Executive and Independent Director
Announcement Reference
SG240913OTHRCPX4
Submitted By (Co./ Ind. Name)
Ong Shen Chieh (Wang Shengjie)
Designation
Executive Director
Description (Please provide a detailed description of the event in the box below)
This announcement has been reviewed by the Company's sponsor, RHT Capital Pte. Ltd. (the "Sponsor"). It has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "Exchange") and the Exchange assumes no responsibility for the contents of this document, including the correctness of any of the statements or opinions made or reports contained in this document.

The contact person for the sponsor is Mr. Khong Choun Mun at 36 Robinson Road, #10-06 City House, Singapore 068877, Email: sponsor@rhtgoc.com.

Additional Details

Name Of Person
Seet Kah Wai (Xue Jiawei)
Age
44
Is effective date of cessation known?
Yes
If yes, please provide the date
30/09/2024
Detailed Reason (s) for cessation
Mr Seet Kah Wai (Xue Jiawei) ("Mr Seet") has resigned as a Non-Executive Director and Independent Director to focus on his other work commitments / existing principal commitments.

After having interviewed Mr Seet and to the best of its knowledge, the Sponsor is satisfied that there are no other material reasons for the cessation of Mr Seet as a Non-Executive and Independent Director of the Company.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
28/07/2023
Does the AC have a minimum of 3 members (taking into account this cessation)?
Yes
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
3
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
1
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Non-Executive and Independent Director, Chairman of the Audit Committee, and a member of the Nominating Committee and Remuneration Committee
Role and responsibilities
Non-Executive
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
Nil
Shareholding interest in the listed issuer and its subsidiaries?
No
Past (for the last 5 years)
(1) Cornerstone Asia Health Pte. Ltd.

(2) Bobcheng Pte. Ltd.

(3) GS Medic Pte. Ltd.

(4) Ng Tay Meng G.I. HEP. Services Pte. Ltd.

(5) Ng Tay Meng Gastrointestinal and Liver Clinic Pte. Ltd.

(6) RSI Medical Pte. Ltd.

(7) Skin Consultancy Pte. Ltd.

(8) Uro Centre Pte. Ltd.

(9) Urology Novena Pte. Ltd.

(10) Urology Surgery Pte. Ltd.

(11) Salvia Ventures Pte. Ltd.
Present
(1) V2Y Corporation Ltd.

(2) Mi Equipment Pte. Ltd.

(3) Suzhou Mi Equipment Co., Ltd.